Elra, or ex vivo liver resection and autotransplantation, offers a promising solution for patients with hepatic alveolar echinococcosis facing cavernous transformation of the portal vein.
- No intraoperative mortality in both treatment groups; 90-day mortality was 16.7%.
- Long-term survival for CTPV patients undergoing elra was 72.9%, compared to 29.6% for those treated conservatively.
The data supports elra as a safe option that significantly enhances long-term survival, even with CTPV present.
- Longest operative times and more blood transfusions were needed for the CTPV group; pleural effusion was the most common complication.
Journal Article by Yilihaer Y, Wang ML (…) Aji T et 3 al. in Hepatobiliary Pancreat Dis Int
Copyright © 2025 First Affiliated Hospital, Zhejiang University School of Medicine in China. Published by Elsevier B.V. All rights reserved.